PRÉPARATION CONTENANT UN ANTICORPS

The present invention relates to stable antibody-containing solution formulations in which aggregate formation of Emicizumab (ACE910) which is a bispecific antibody functionally substituting for FVIII, is suppressed. Specifically, the present invention relates to the above-mentioned antibody-contain...

Full description

Saved in:
Bibliographic Details
Main Authors SASAKI, Hitoshi, SAEKI, Atsushi, IGAWA, Tomoyuki, NISHIZAWA, Shaw, IMAI, Chifumi
Format Patent
LanguageFrench
Published 06.03.2019
Subjects
Online AccessGet full text

Cover

Loading…